names of glp-1 5 trends to expect in 2026: Expanded uses, oral options, and more glp 1 receptor agonists brand

[17] When significant weight loss occurswhether through lifestyle modification, bariatric surgery, or pharmacotherapythere may be improvements in HPA axis function

GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)

How Microdosing Tirzepatide Became a Trend Microdosing tirzepatide has become an emerging area of interest, discussed on social media and within wellness circles

"There will be a small proportion of people, 10% maximum, that are able to maintain [all] the weight they've lost," says Alex Miras, a clinical professor of medicine at Ulster University

By combining essential micronutrients that are typically under-consumed during appetite suppression, these vitamins offer targeted support to sustain metabolic and cellular functions